BioMarin Pharmaceutical Inc.
US ˙ NasdaqGS ˙ US09061G1013

SecurityBMRN / BioMarin Pharmaceutical Inc.
InstitutionAdvisory Services Network, LLC
Latest Disclosed Ownership409 shares
Latest Disclosed Value $ 23,105
Advisory Services Network, LLC ownership in BMRN / BioMarin Pharmaceutical Inc.

On May 15, 2026 - Advisory Services Network, LLC filed a 13F-HR form disclosing ownership of 409 shares of BioMarin Pharmaceutical Inc. (US:BMRN) valued at $23,104 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 0 shares of BioMarin Pharmaceutical Inc.. The current value of the position is $23,096 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 409 409 23 0.0002
2026-02-17 2025-12-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 0 -286 -100.00 0 -100.00
2025-11-18 2025-09-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 286 286 15 0.0002
2024-05-06 2024-03-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 0 -327 -100.00 0 -100.00
2024-02-09 2023-12-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 327 327 32 0.0008
2023-08-09 2023-06-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 0 -429 -100.00 0 -100.00
2023-05-17 2023-03-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 429 102 31.19 42 24.24 0.0012
2023-02-13 2022-12-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 327 327 34 0.0010
2021-11-05 2021-09-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 0 -501 -100.00 0 -100.00
2021-08-12 2021-06-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 501 501 41 0.0013
2021-05-24 2021-03-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 0 -534 -100.00 0 -100.00
2021-02-09 2020-12-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 534 173 47.92 47 67.86 0.0019
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 361 361 -32.40 28 -40.43 0.0013
2020-08-10 2020-06-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 0 -252 -100.00 0 -100.00
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 252 26 11.50 22 15.79 0.0014
2020-02-04 2019-12-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 226 4 1.80 19 5.56 0.0010
2019-11-04 2019-09-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 222 0 0.00 18 0.00 0.0011
2019-08-01 2019-06-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 222 15 7.25 18 -5.26 0.0011
2019-05-20 2019-03-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 207 -546 -72.51 19 -70.31 0.0013
2019-02-15 2018-12-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 753 86 12.89 64 -1.54 0.0056
2018-11-02 2018-09-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 667 42 6.72 65 1.56 0.0047
2018-07-27 2018-06-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 625 526 531.31 64 700.00 0.0049
2018-04-23 2018-03-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 99 0 0.00 8 -11.11 0.0006
2018-02-08 2017-12-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 99 0 0.00 9 0.00 0.0008
2017-10-12 2017-09-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 99 0 0.00 9 0.00 0.0010
2017-08-17 2017-06-30 13F BIOMARIN PHARMACEUTICAL INC COM Stock 09061G101 99 0 0.00 9 0.00 0.0012
2017-04-28 2017-03-31 13F BIOMARIN PHARMACEUTICAL INC COM Stock 09061G101 99 -148 -59.92 9 -60.87 0.0013
2016-10-07 2016-09-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 247 -285 -53.57 23 -43.90 0.0043
2016-07-27 2016-06-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 532 483 985.71 41 925.00 0.0093
2016-04-21 2016-03-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 49 0 0.00 4 -20.00 0.0011
2016-01-27 2015-12-31 13F BIOMARIN PHARMACEUTICAL INC COM Stock 09061G101 49 -908 -94.88 5 -95.05 0.0016
2015-10-01 2015-09-30 13F BIOMARIN PHARMACEUTICAL INC COM Stock 09061G101 957 137 16.71 101 -9.82 0.0305
2015-07-02 2015-06-30 13F BIOMARIN PHARMACEUTICAL INC COM Stock 09061G101 820 -91 -9.99 112 3.70 0.0330
2015-04-08 2015-03-31 13F BIOMARIN PHARMACEUTICAL INC COM Stock 09061G101 911 862 1,759.18 108 2,060.00 0.0298
2015-01-23 2014-12-31 13F BIOMARIN PHARMACEUTICAL INC COM Stock 09061G101 49 49 5 0.0016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.